Page last updated: 2024-10-25

cilostamide and Aortic Valve Stenosis

cilostamide has been researched along with Aortic Valve Stenosis in 1 studies

cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure

Aortic Valve Stenosis: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.

Research Excerpts

ExcerptRelevanceReference
"Cardiac hypertrophy was induced in rats by thoracic aortic banding over a time period of 5 weeks and was confirmed by anatomic measurements and echocardiography."1.35Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals. ( Abi-Gerges, A; Conti, M; Fischmeister, R; Heymes, C; Lefebvre, F; Lugnier, C; Mateo, P; Richter, W; Samuel, JL; Vandecasteele, G; Varin, A, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abi-Gerges, A1
Richter, W1
Lefebvre, F1
Mateo, P1
Varin, A1
Heymes, C1
Samuel, JL1
Lugnier, C1
Conti, M1
Fischmeister, R1
Vandecasteele, G1

Other Studies

1 other study available for cilostamide and Aortic Valve Stenosis

ArticleYear
Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.
    Circulation research, 2009, Oct-09, Volume: 105, Issue:8

    Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Aortic Valve S

2009